This webinar focuses on the global development and distribution of COVID-19 vaccines, including issues around equitable distribution and disinformation, as well as stories of success.
This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.
This webinar featured a panel discussion with experts from around the world who presented on the areas of dementia risk reduction, NCDs, air pollution, and the lived experience of dementia during COVID-19.
This webinar focuses on key issues emerging around dementia care and palliative care during the COVID-19 pandemic, and crucially how these can be taken forward.
This webinar focuses on how ADI’s member associations from around the world have been innovating and adapting to a COVID-19 world.
This webinar focuses on the emergency within care homes and day care centres during the COVID-19 pandemic, as well as the new set of challenges that are being presented as a result.
This webinar focuses on what a post-COVID world may look like for people living with dementia.
This webinar features key speakers from ADI's member associations who share their experiences of adapting to the COVID-19 pandemic.